# Kisspeptin: An Editorial Review of What the Human Trials Actually Found > Kisspeptin is the upstream switch of the reproductive axis. An editorial review of the published literature — the IVF trigger, the bone and metabolism signals, and the tachyphylaxis limit, all cited. A study-by-study reading of the published record: the IVF oocyte-maturation trigger that avoided ovarian hyperstimulation, the restored hormone pulses in women who had lost them, the early bone and metabolism signals, and the limit nobody designs around — the response fades with continuous use. ## The short version Kisspeptin is a small signaling molecule your body already makes. Think of it as the master switch sitting one step above the whole reproductive system. When a tiny group of brain cells releases kisspeptin, it tells the next set of cells to release GnRH (gonadotropin-releasing hormone — the hormone that kicks off the chain), which tells the pituitary gland to send out LH and FSH (the two messenger hormones that act on the ovaries and testes), which then make estrogen or testosterone. Kisspeptin is upstream of all of that. It is not a sex hormone itself, and it is not the same as the GnRH drugs used in fertility clinics. In supervised studies, doctors have used kisspeptin to trigger egg maturation during IVF, to restart hormone cycles in women who had stopped having periods, and to briefly raise testosterone in men. People in research communities also report effects on sex drive — covered honestly, and clearly labeled as anecdotal, on [the effects page](/effects). The catch: the effect fades if you give it constantly, and no health authority has approved it for anything. It is investigational, and despite the search term, it is not a dietary supplement. ## What is kisspeptin Kisspeptin is the protein product of the KISS1 gene, and it works by binding a single receptor called KISS1R (originally named GPR54 — a docking site on the surface of certain brain cells). That receptor sits on the GnRH neurons of the hypothalamus, the deep brain region that governs reproduction. When kisspeptin docks, those neurons fire and release GnRH in pulses, and the rest of the hormonal cascade follows [1]. The finding that anchored the whole field came in 2003. Researchers found that people born with a broken GPR54 gene failed to go through puberty, and mice engineered the same way reproduced the defect exactly [1]. That single observation reframed kisspeptin from an obscure gene product into the upstream gatekeeper of human reproduction. Everything on this site reads outward from that result. Kisspeptin comes in a few lengths, all cut from the same precursor. The longest research isoform is kisspeptin-54 (the original name was metastin); the shortest commonly studied one is kisspeptin-10. Both end in the same chemical motif the receptor recognizes, so both are active — they differ mainly in how long they last in the body, which matters a great deal for how they behave in a study [3]. ## Kisspeptin reviews: what the evidence actually shows This site is a reviews project, so the honest summary leads. The strongest, most reproducible human result is reproductive, not metabolic: in a Phase 2 randomized trial of 60 women at high risk of ovarian hyperstimulation syndrome (OHSS — a serious over-response to IVF drugs), a single subcutaneous dose of kisspeptin-54 triggered egg maturation in 95% of women, with no case of moderate, severe, or critical OHSS at any dose [5]. That is the result the literature keeps returning to. Close behind it: in women with hypothalamic amenorrhea (missed periods caused by stress, low body weight, or heavy training), a continuous infusion of kisspeptin-54 restored the natural rhythm of LH release, roughly tripling pulse frequency and raising the hormone output about six-fold versus placebo [4]. In healthy men, an intravenous bolus of kisspeptin-10 raised LH about three-fold within half an hour, and a higher continuous rate nudged testosterone up modestly [3]. The metabolism-and-bone angle this review is built around is real but smaller. A short kisspeptin infusion in healthy men raised markers of bone formation by about 20% [11], and decades of animal and human work tie kisspeptin neurons to the body's energy state through the hormone leptin [8][9]. But a careful human study found no effect on hunger or food intake [10] — so kisspeptin is not, on current evidence, an appetite or weight-loss agent. The [kisspeptin benefits](/benefits) and [kisspeptin side effects](/side-effects) pages weigh each of these in detail. ## Kisspeptin supplement: an honest distinction A common search is "kisspeptin supplement," so the plain answer belongs here: kisspeptin is not a dietary supplement. It is a peptide hormone studied as an investigational drug in clinical trials, given by injection or nasal spray under medical supervision [7]. It is not sold as a capsule, it is not regulated as a supplement, and no regulator has approved it for any use. That distinction matters for a second reason. Because kisspeptin acts on the master reproductive switch, the doses described in the literature are research protocols — reported here only as "studied at X in [population] by [route]" — never as instructions. There is no established human therapeutic dose. Where dosing and schedule are discussed at all, the defining limitation appears with them: tachyphylaxis, the rapid fading of response under continuous or high-dose exposure, which the trials documented directly [4][16]. This review never recommends a dose, and the [Kisspeptin research](/research) page keeps every number tied to the study and population it came from. Every claim on this site maps to the full [Kisspeptin references](/references) list, with DOIs and PubMed links for each source. --- A nocturne reading of the kisspeptin literature — the upstream KISS1R switch weighed study by study, the IVF and amenorrhea results led with, the metabolism and bone signals kept in proportion, and the tachyphylaxis limit left openly in view; no clinic behind the lamplight and nothing here dispensed, prescribed, or sold.